COSCIENS Biopharma (CSCI) Announces Resignation of Carolyn Egbert from Board

COSCIENS Biopharma Inc. (NASDAQ: CSCI) today announced the resignation of Carolyn Egbert from the Board of Directors, effective immediately.

“We are extremely grateful to Carolyn for her twelve years of dedicated service to the Company as a member of the Board of Directors, including serving eight years as Chair. Throughout her tenure as a board member of Aeterna Zentaris, now CONSCIENS, she provided valuable contributions and insight,” said Chair of the Board, Ronald Miller. “With Carolyn’s decision to resign from the Board and as the Company continues to evolve at various levels, we have made the strategic decision to streamline our board structure and move forward with six members, including five independent directors which we believe more closely aligns with the industry standard for a Company at our stage.”

You May Also Be Interested In

• Virtus Investment Partners names Jack Boyce to its board
• James Hardie sells Fermacell unit to Holcim for €840 million
• Getty Realty discloses separation terms for departing accounting officer